1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      A comprehensive narrative review of diagnostic biomarkers in human primary membranous nephropathy.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Membranous nephropathy (MN) is relatively major cause of nephrotic syndrome in adults which is recognized as an organ-specific autoimmune disease. The etiology of most cases is idiopathic, whereas the secondary MN is caused by systemic autoimmune diseases, infections, medications and malignancies. The idiopathic disease is developed by the formation of sub-epithelial immune complex deposits most likely due to binding the circulating auto-antibodies to intrinsic antigen on podocytes. The major auto antibody is the anti-phospholipase A2 receptor (anti-PLA2R), however, it is not enough sensitive. Several attempts for diagnostic biomarker identification by modern analytical technologies have been devoted recently. This article reviews the biomarker candidates for primary type of MN that are detected by different approaches on human subjects.

          Related collections

          Author and article information

          Journal
          Biomark Med
          Biomarkers in medicine
          Future Medicine Ltd
          1752-0371
          1752-0363
          Sep 11 2017
          Affiliations
          [1 ] Chronic Kidney Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
          [2 ] Urology Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
          Article
          10.2217/bmm-2017-0081
          28891307
          94a66405-5a04-47b3-8d67-faf9dec5fe03
          History

          idiopathic,auto-antibodies,complement pathway,diagnostic biomarkers,immune complex,membranous nephropathy,metabolomics,proteomics,transcriptomics,anti-PLA2R

          Comments

          Comment on this article